| dc.contributor.advisor | 吳文傑 | zh_TW |
| dc.contributor.advisor | Wu, Jack | en_US |
| dc.contributor.author (Authors) | 鍾添坤 | zh_TW |
| dc.contributor.author (Authors) | Chung, David | en_US |
| dc.creator (作者) | 鍾添坤 | zh_TW |
| dc.creator (作者) | Chung, David | en_US |
| dc.date (日期) | 2008 | en_US |
| dc.date.accessioned | 14-Sep-2009 09:48:36 (UTC+8) | - |
| dc.date.available | 14-Sep-2009 09:48:36 (UTC+8) | - |
| dc.date.issued (上傳時間) | 14-Sep-2009 09:48:36 (UTC+8) | - |
| dc.identifier (Other Identifiers) | G0094933010 | en_US |
| dc.identifier.uri (URI) | https://nccur.lib.nccu.edu.tw/handle/140.119/31330 | - |
| dc.description (描述) | 碩士 | zh_TW |
| dc.description (描述) | 國立政治大學 | zh_TW |
| dc.description (描述) | 國際經營管理碩士班(IMBA) | zh_TW |
| dc.description (描述) | 94933010 | zh_TW |
| dc.description (描述) | 97 | zh_TW |
| dc.description.abstract (摘要) | 疫苗發展作為台灣生技產業發展中主要領域中之一項 | zh_TW |
| dc.description.abstract (摘要) | None | en_US |
| dc.description.abstract (摘要) | 1. Introduction 4 1.1 Taiwan’s Biotechnology Industry 9 1.2 Development Strategy of Biotech Industry 14 2. Vaccine Industry 16 2.1 Taiwan’s vaccine development history 16 2.2 Vaccines Product Approval Process 20 3. ADImmune 24 3.1 ADImmune’s development history 24 3.2 SWOT Analysis of ADImmune 28 3.2.1. Strength 28 3.2.2. Weakness 29 3.2.3. Opportunities 30 3.2.4. Threats 31 3.3 Vision and Intermediate Goals 31 3.4 Future Perspectives 32 References 38 Table and Figures Figure 1. The life cycle of drug development 10 Table 1. Supply and Demand of Biotech and Pharmaceutical products in Taiwan, 2005 11 Figure 2. Development strategy of biotech industry 14 Table 2. Recommended Vaccination Schedules in Asia Pacific, 2005 17 Figure 3. Review Process of New Drug Approval in Taiwan 21 Fig 4. Future Perspective: vaccine industry policy 37 | - |
| dc.description.tableofcontents | 1. Introduction 4 1.1 Taiwan’s Biotechnology Industry 9 1.2 Development Strategy of Biotech Industry 14 2. Vaccine Industry 16 2.1 Taiwan’s vaccine development history 16 2.2 Vaccines Product Approval Process 20 3. ADImmune 24 3.1 ADImmune’s development history 24 3.2 SWOT Analysis of ADImmune 28 3.2.1. Strength 28 3.2.2. Weakness 29 3.2.3. Opportunities 30 3.2.4. Threats 31 3.3 Vision and Intermediate Goals 31 3.4 Future Perspectives 32 References 38 Table and Figures Figure 1. The life cycle of drug development 10 Table 1. Supply and Demand of Biotech and Pharmaceutical products in Taiwan, 2005 11 Figure 2. Development strategy of biotech industry 14 Table 2. Recommended Vaccination Schedules in Asia Pacific, 2005 17 Figure 3. Review Process of New Drug Approval in Taiwan 21 Fig 4. Future Perspective: vaccine industry policy 37 | zh_TW |
| dc.language.iso | en_US | - |
| dc.source.uri (資料來源) | http://thesis.lib.nccu.edu.tw/record/#G0094933010 | en_US |
| dc.subject (關鍵詞) | 疫苗發展 | zh_TW |
| dc.title (題名) | 疫苗發展作為台灣生技產業發展中主要領域中之一項─國光生技公司案例研究 | zh_TW |
| dc.title (題名) | Vaccine Development as One of Key Areas Towards Developing Biopharma Industry of Taiwan－ ADImmune case study | en_US |
| dc.type (資料類型) | thesis | en |
| dc.relation.reference (參考文獻) | 1. Centers for Disease Control, Taiwan. Website: www.cdc.gov.tw/mp.asp?mp=1 | zh_TW |
| dc.relation.reference (參考文獻) | 2. Kang Sim and Hong Choon Chua, The psychological impact of SARS: a matter of heart and mind. Commentary CMAJ, 2004; 170(5):811. | zh_TW |
| dc.relation.reference (參考文獻) | 3. White Paper for Small and Medium-Sized Enterprise, 2004. Ministry of Economic Affairs, R.O.C. | zh_TW |
| dc.relation.reference (參考文獻) | 4. Der-Fu Chou. Thesis: The study of national security of ROC. P.17. May 2004 | zh_TW |
| dc.relation.reference (參考文獻) | 5. Mei-Hwei Chang, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. NEJM 1997; 336(26):1855-59. | zh_TW |
| dc.relation.reference (參考文獻) | 6. Ming-I Liaw. Taiwan’s vaccine development. Science Monthly (Chinese). Jul 1999. | zh_TW |
| dc.relation.reference (參考文獻) | 7. Chan-Ming Wang, News report, Libertytimes. November 7, 2004. | zh_TW |
| dc.relation.reference (參考文獻) | 8. DiMasi JA et al. J Health Economics 2003; 22:151-85. | zh_TW |
| dc.relation.reference (參考文獻) | 9. Chi-Hsiang Chen. Taiwan Biotechnology and Pharmaceutical Industry Program Office, MOEA statistics, 2006 | zh_TW |
| dc.relation.reference (參考文獻) | 10. Taiwan cancer registry, statistics 1995-2006. | zh_TW |
| dc.relation.reference (參考文獻) | 11. Crucell in Glodman Sachs 29th Annual Global Healthcare Conference. Jun 10th, 2008. Dana Point, California. | zh_TW |
